WALLIX GROUP Valuation

Is ALLIX undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ALLIX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: ALLIX (€9.3) is trading below our estimate of fair value (€155.34)

Significantly Below Fair Value: ALLIX is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for ALLIX?

Key metric: As ALLIX is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for ALLIX. This is calculated by dividing ALLIX's market cap by their current revenue.
What is ALLIX's PS Ratio?
PS Ratio1.8x
Sales€34.81m
Market Cap€61.57m

Price to Sales Ratio vs Peers

How does ALLIX's PS Ratio compare to its peers?

The above table shows the PS ratio for ALLIX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3x
ALTAI LightOn SAS
10.6xn/a€87.1m
VMX Verimatrix
0.4x4.4%€23.2m
PROAC Proactis
0.8xn/a€9.0m
EOS Acteos
0.2xn/a€3.4m
ALLIX WALLIX GROUP
1.8x18.8%€61.6m

Price-To-Sales vs Peers: ALLIX is good value based on its Price-To-Sales Ratio (1.8x) compared to the peer average (3x).


Price to Sales Ratio vs Industry

How does ALLIX's PS Ratio compare vs other companies in the FR Software Industry?

5 CompaniesPrice / SalesEstimated GrowthMarket Cap
CLA Claranova
0.2x5.0%US$81.99m
VMX Verimatrix
0.4x4.4%US$24.50m
ALPRG Prologue
0.2x3.4%US$18.28m
EOS Acteos
0.2xn/aUS$3.59m
ALLIX 1.8xIndustry Avg. 2.1xNo. of Companies5PS0246810+
5 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: ALLIX is good value based on its Price-To-Sales Ratio (1.8x) compared to the French Software industry average (2.1x).


Price to Sales Ratio vs Fair Ratio

What is ALLIX's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ALLIX PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.8x
Fair PS Ratio2.6x

Price-To-Sales vs Fair Ratio: ALLIX is good value based on its Price-To-Sales Ratio (1.8x) compared to the estimated Fair Price-To-Sales Ratio (2.6x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ALLIX forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€9.30
€13.50
+45.2%
11.1%€15.00€12.00n/a2
Dec ’25€10.20
€13.50
+32.4%
11.1%€15.00€12.00n/a2
Nov ’25€9.47
€13.50
+42.6%
11.1%€15.00€12.00n/a2
Oct ’25€9.00
€13.50
+50.0%
11.1%€15.00€12.00n/a2
Sep ’25€7.98
€13.50
+69.2%
11.1%€15.00€12.00n/a2
Aug ’25€7.86
€13.50
+71.8%
11.1%€15.00€12.00n/a2
Jul ’25€9.00
€16.00
+77.8%
6.3%€17.00€15.00n/a2
Jun ’25€9.45
€16.50
+74.6%
3.0%€17.00€16.00n/a2
May ’25€8.68
€16.50
+90.1%
3.0%€17.00€16.00n/a2
Apr ’25€8.30
€16.50
+98.8%
3.0%€17.00€16.00n/a2
Mar ’25€10.30
€17.00
+65.0%
5.9%€18.00€16.00n/a2
Feb ’25€8.68
€17.00
+95.9%
5.9%€18.00€16.00n/a2
Jan ’25€9.24
€17.00
+84.0%
5.9%€18.00€16.00n/a2
Dec ’24€9.76
€17.00
+74.2%
5.9%€18.00€16.00€10.202
Nov ’24€7.75
€17.00
+119.4%
5.9%€18.00€16.00€9.472
Oct ’24€9.05
€17.00
+87.8%
5.9%€18.00€16.00€9.002
Sep ’24€10.50
€17.00
+61.9%
5.9%€18.00€16.00€7.982
Aug ’24€10.56
€17.00
+61.0%
5.9%€18.00€16.00€7.862
Jul ’24€10.10
€18.00
+78.2%
11.1%€20.00€16.00€9.002
Jun ’24€13.28
€19.00
+43.1%
5.3%€20.00€18.00€9.452
May ’24€11.70
€19.00
+62.4%
5.3%€20.00€18.00€8.682
Apr ’24€9.61
€19.00
+97.7%
5.3%€20.00€18.00€8.302
Mar ’24€12.38
€19.00
+53.5%
5.3%€20.00€18.00€10.302
Feb ’24€14.88
€19.00
+27.7%
5.3%€20.00€18.00€8.682
Jan ’24€11.80
€19.00
+61.0%
5.3%€20.00€18.00€9.242
Dec ’23€11.30
€19.00
+68.1%
5.3%€20.00€18.00€9.762

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies